[Intraoperative radiotherapy of breast cancer].
In the systemic therapy of breast cancer, the tumor itself has become the specific target. If possible the surgical excision of breast carcinoma is restricted to the tumor site and aims at an R0 resection of the invasive and preinvasive portions of the carcinoma. Only percutaneous whole-breast radiotherapy irradiates the whole breast. The additional boost irradiation is targeted and significantly improves local control in all age groups. Due to the increased detection of small breast carcinomas in postmenopausal patients by mammographic screening, it is necessary to consider a change of the existing therapeutic practice. Published results of partial irradiation of the breast (intra- as well as postoperatively) show a very high degree of local control with follow-ups of up to 11 years. At present prospective and randomized studies investigate for which patients an intraoperative radiotherapy is sufficient as the sole irradiation method after previous surgery. Intraoperative radiotherapy as a boost preceding percutaneous whole-breast irradiation should already be possible according to a relevant statement of the DEGRO.
Blohmer
Jens Uwe
JU
Brustzentrum City, Klinik fur Frauenheilkunde und Geburtshilfe, St.-Gertrauden-Krankenhaus Berlin, Berlin, Deutschland. Jens.Blohmer@sankt-gertrauden.de
Kimmig
Rainer
R
Kummel
Sherko
S
Costa
Serban-Dan
SD
Kramer
Stefan
S
Rezai
Mahdi
M
D001943:Breast Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D007430:Intraoperative Care / Q000639:trends*; D010818:Practice Patterns, Physicians' / Q000639:trends*; D018714:Radiotherapy, Adjuvant / Q000639:trends*